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Background:  Galectin-3, growth differentiation factor 15 (GDF-15) and N-terminal segment of B-type natriuretic peptide prohormone (NT-proBNP) 
are elevated in patients with acute myocardial infarction (AMI), thus providing prognostic information. However, the best time point to determine 
these biomarkers remains unclear. The aim of the present study was to determine the time course of galectin-3, GDF-15, and NT-proBNP release in 
patients undergoing transcoronary ablation of septal hypertrophy (TASH), a procedure that mimics AMI.
Methods: Consecutive patients (n=21) with hypertrophic obstructive cardiomyopathy undergoing TASH were included. Blood samples were 
collected prior to TASH and 15, 30, 45, 60, 75, 90, and 105 min and 2, 4, 8, and 24 h after TASH. Galectin-3 and GDF-15 were quantified in plasma 
and NT-proBNP was quantified in serum using immunoassays.
Results: The concentrations of galectin-3 showed a continuous increase during the first hour after induction of myocardial infarction with the first 
significant change compared with the baseline value occurring 30 min after TASH (112.1% IQR [100.3-124.9%] vs. baseline 100% IQR [100%]; 
P=0.007). Galectin-3 levels decreased from the baseline value 24 h after TASH (90.5% IQR [80.4-103.3%] vs. baseline 100% IQR [100%]; P=0.015). 
The concentrations of GDF-15 underwent the first significant change 24 h after induction of myocardial infarction (119.1% IQR [104.7-152.7%] 
vs. baseline 100% IQR [100%]; P=0.003). The levels of NT-proBNP showed a continuous increase during the first 75 min with a significant change 
compared with the baseline value occurring as early as 15 min after TASH (105.6% [IQR 102.2-112.7]; P<0.001). The levels of NT-proBNP decreased 
from the baseline value until 8 h after initiation of myocardial infarction.
conclusion: Galectin-3, GDF-15 and NT-proBNP showed different release kinetics after induction of myocardial infarction. Galectin-3 and NT-
proBNP levels increased early whereas GDF-15 levels increased very late after TASH. These findings provide additional information about these 
biomarkers that could be used for risk stratification in patients with AMI.
